ArticleBMC gastroenterology2021

Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.

Niels Teich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.